These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7544152)

  • 1. Flow cytometric analysis of decay-accelerating factor (CD55) on neutrophils from aplastic anaemia patients.
    Forés R; Alcocer M; Diez-Martin JL; Fernandez MN
    Br J Haematol; 1995 Jul; 90(3):728-30. PubMed ID: 7544152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of PNH clones using flow cytometry in aplastic anemia and paroxysmal nocturnal hemoglobinuria].
    Forés R; Alcocer M; Cabrera R; Sanjuán I; Briz M; Lago C; Fernández MN
    Sangre (Barc); 1999 Jun; 44(3):199-203. PubMed ID: 10481581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on the expression of complement regulatory proteins in three kinds of stem cell defect anemias and its clinical implications].
    Xu C; Zhang T; Zhao R
    Zhonghua Xue Ye Xue Za Zhi; 1999 Oct; 20(10):511-4. PubMed ID: 11721394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decay-accelerating factor and CD59 expression in peripheral blood cells in aplastic anaemia and report of a case of paroxysmal nocturnal haemoglobinuria secondary to aplastic anaemia.
    Fujioka S; Yamada T
    Br J Haematol; 1993 Apr; 83(4):660-2. PubMed ID: 7686037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of PI-bound proteins on blood cells from PNH patients by quantitative flow cytometry.
    Plesner T; Hansen NE; Carlsen K
    Br J Haematol; 1990 Aug; 75(4):585-90. PubMed ID: 1698448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of CD55 and/or CD59 deficient red cell populations in patients with aplastic anaemia, myelodysplastic syndromes and myeloproliferative disorders.
    Meletis J; Terpos E; Samarkos M; Meletis C; Konstantopoulos K; Komninaka V; Apostolidou E; Benopoulou O; Korovesis K; Mavrogianni D; Variami E; Yataganas X; Loukopoulos D
    Haematologia (Budap); 2001; 31(1):7-16. PubMed ID: 11345408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia.
    Sugimori C; Chuhjo T; Feng X; Yamazaki H; Takami A; Teramura M; Mizoguchi H; Omine M; Nakao S
    Blood; 2006 Feb; 107(4):1308-14. PubMed ID: 16179371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosylphosphatidyl-inositol (GPI)-linked protein deficiency on the platelets of patients with aplastic anaemia and paroxysmal nocturnal haemoglobinuria: two distinct patterns correlating with expression on neutrophils.
    Jin JY; Tooze JA; Marsh JC; Gordon-Smith EC
    Br J Haematol; 1997 Mar; 96(3):493-6. PubMed ID: 9054654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of paroxysmal nocturnal haemoglobinuria by phenotypic analysis of erythrocytes using two-colour flow cytometry with monoclonal antibodies to DAF and CD59/MACIF.
    Shichishima T; Terasawa T; Saitoh Y; Hashimoto C; Ohto H; Maruyama Y
    Br J Haematol; 1993 Oct; 85(2):378-86. PubMed ID: 7506570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two distinct patterns of glycosylphosphatidylinositol (GPI) linked protein deficiency in the red cells of patients with paroxysmal nocturnal haemoglobinuria.
    Hillmen P; Hows JM; Luzzatto L
    Br J Haematol; 1992 Mar; 80(3):399-405. PubMed ID: 1374629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of glycosyl-phosphatidylinositol-linked glycoproteins in blood cells from paroxysmal nocturnal haemoglobinuria patients: a flow cytometry study using CD55, CD58 and CD59 monoclonal antibodies.
    Navenot JM; Bernard D; Harousseau JL; Muller JY; Blanchard D
    Leuk Lymphoma; 1996 Mar; 21(1-2):143-51. PubMed ID: 8907282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogenous expression of decay accelerating factor and CD59/membrane attack complex inhibition factor on paroxysmal nocturnal haemoglobinuria (PNH) erythrocytes.
    Shichishima T; Terasawa T; Hashimoto C; Ohto H; Uchida T; Maruyama Y
    Br J Haematol; 1991 Aug; 78(4):545-50. PubMed ID: 1716957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the DAF (CD55) and CD59 antigens during normal hematopoietic cell differentiation.
    Terstappen LW; Nguyen M; Lazarus HM; Medof ME
    J Leukoc Biol; 1992 Dec; 52(6):652-60. PubMed ID: 1281489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of CD55 and CD59 expression on reticulocytes and mature erythrocytes in paroxysmal nocturnal hemoglobinuria, aplastic anemia, and healthy control subjects.
    Kim Y; Lim J; Kim M; Kim Y; Lee JW; Han K
    Ann Clin Lab Sci; 2010; 40(3):226-32. PubMed ID: 20689133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of hematologic recovery in patients with aplastic anemia following cyclosporine therapy.
    Yamaguchi M; Nakao S; Takamatsu H; Chuhjo T; Shiobara S; Matsuda T
    Exp Hematol; 1995 Apr; 23(4):341-6. PubMed ID: 7534714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease-modified erythrocytes: CD55 and CD59 deficient PNH-like cells.
    Yuan FF; Bryant JA; Fletcher A
    Immunol Cell Biol; 1995 Feb; 73(1):66-72. PubMed ID: 7539403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glycosilphosphatidylinositol-anchored cell surface protein deficiency in Mexican mestizo patients with aplastic anemia].
    Ruiz-Argüelles GJ; Ramírez Cisneros FJ; Ruiz-Argüelles A; Pérez-Romano B; Morales-Aceves R
    Rev Invest Clin; 1999; 51(1):5-9. PubMed ID: 10344161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different expression and mobilisation of the complement regulatory proteins CD35, CD55 and CD59 in neonatal and adult neutrophils.
    Lothian C; Dahlgren C; Lagercrantz H; Lundahl J
    Biol Neonate; 1997; 72(1):15-21. PubMed ID: 9313830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of Fc gamma R-III (CD16) expression on neutrophils affected by paroxysmal nocturnal haemoglobinuria by administration of granulocyte colony-stimulating factor.
    Ninomiya H; Muraki Y; Shibuya K; Nagasawa T; Abe T
    Br J Haematol; 1993 Jul; 84(3):497-503. PubMed ID: 7692930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with recombinant human erythropoietin (rHuEpo) in a patient with paroxysmal nocturnal haemoglobinuria: evaluation of membrane proteins CD55 and CD59 with cytofluorometric assay.
    Astori C; Bonfichi M; Pagnucco G; Bernasconi P; Lazzarino M; Orlandi E; Bernasconi C
    Br J Haematol; 1997 Jun; 97(3):586-8. PubMed ID: 9207404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.